These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12366873)

  • 41. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Double-blind, placebo-controlled, pharmacokinetic and -dynamic studies with 2 new formulations of piracetam (infusion and sirup) under hypoxia in man.
    Saletu B; Hitzenberger G; Grünberger J; Anderer P; Zyhlarz G; Linzmayer L; Rameis H
    Int J Clin Pharmacol Ther; 1995 May; 33(5):249-62. PubMed ID: 7655763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. On central effects of serotonin re-uptake inhibitors: quantitative EEG and psychometric studies with sertraline and zimelidine.
    Saletu B; Grünberger J; Linzmayer L
    J Neural Transm; 1986; 67(3-4):241-66. PubMed ID: 2949057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Slow EEG-power spectra correlate with haemodynamic changes during laryngoscopy and intubation following induction with fentanyl or sufentanil.
    Freye E; Dehnen-Seipel H; Latasch L; Behler M; Wilder-Smith OH
    Acta Anaesthesiol Belg; 1999; 50(2):71-6. PubMed ID: 10418645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
    Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM
    Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EEG brain mapping in diagnostic and therapeutic assessment of dementia.
    Saletu B; Anderer P; Paulus E; Grünberger J; Wicke L; Neuhold A; Fischhof PK; Litschauer G
    Alzheimer Dis Assoc Disord; 1991; 5 Suppl 1():S57-75. PubMed ID: 1781975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Demonstration of the central effects of D,L-kawain with EEG brain mapping].
    Frey R
    Fortschr Med; 1991 Aug; 109(25):505-8. PubMed ID: 1682226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BMS-181168 for protection of the human brain against hypoxia: double-blind, placebo-controlled EEG mapping studies.
    Saletu B; Schulz H; Herrmann WM; Anderer P; Shrotriya RC; Vanbrabant E
    Pharmacopsychiatry; 1994 Sep; 27(5):189-97. PubMed ID: 7838889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hormone replacement therapy and vigilance: double-blind, placebo-controlled EEG-mapping studies with an estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone in menopausal syndrome patients.
    Saletu B; Anderer P; Gruber D; Metka M; Huber J; Saletu-Zyhlarz GM
    Maturitas; 2002 Nov; 43(3):165-81. PubMed ID: 12443834
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Relation between blood levels and average quantitative EEG and psychometrically assessed pharmacodynamic changes following zotepine].
    Saletu B; Grünberger J; Anderer P; Chwatal K
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():45-55. PubMed ID: 1683340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative EEG and psychometric analyses in assessing CNS-activity of Ro 13-5057--a cerebral insufficiency improver.
    Saletu B; Grünberger J; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1980 Oct; 2(5):269-85. PubMed ID: 6927816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Objective measures in determining the central effectiveness of a new antihypoxidotic SL-76188: pharmaco-EEG, psychometric and pharmacokinetic analyses in the elderly.
    Grünberger J; Saletu B; Linzmayer L; Stöhr H
    Arch Gerontol Geriatr; 1982 Nov; 1(3):261-85. PubMed ID: 6764605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative pharmaco-electroencephalographic differentiation between the CNS effects of bromocriptine and imipramine, drugs with qualitatively different antidepressant properties.
    Yamadera H; Ferber G; Matejcek M; Pokorny R
    Pharmacopsychiatry; 1987 Mar; 20(2):54-9. PubMed ID: 3588662
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmaco-EEG profiles of typical and atypical antidepressants.
    Saletu B
    Adv Biochem Psychopharmacol; 1982; 32():257-68. PubMed ID: 7090895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmaco-EEG, behavioural methods and blood levels in the comparison of temazepam and flunitrazepam.
    Saletu B; Grünberger J; Sieghart W
    Acta Psychiatr Scand Suppl; 1986; 332():67-94. PubMed ID: 2883830
    [TBL] [Abstract][Full Text] [Related]  

  • 56. On brain protection of co-dergocrine mesylate (Hydergine) against hypoxic hypoxidosis of different severity: double-blind placebo-controlled quantitative EEG and psychometric studies.
    Saletu B; Grünberger J; Anderer R
    Int J Clin Pharmacol Ther Toxicol; 1990 Dec; 28(12):510-24. PubMed ID: 2086492
    [TBL] [Abstract][Full Text] [Related]  

  • 57. EEG profile of intravenous zolpidem in healthy volunteers.
    Patat A; Trocherie S; Thebault JJ; Rosenzweig P; Dubruc C; Bianchetti G; Court LA; Morselli PL
    Psychopharmacology (Berl); 1994 Feb; 114(1):138-46. PubMed ID: 7846196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmaco-EEG study of 6-azamianserin (ORG 3770): dissociation of EEG and pharmacologic predictors of antidepressant activity.
    Fink M; Irwin P
    Psychopharmacology (Berl); 1982; 78(1):44-8. PubMed ID: 6815696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychotropic profile of S 17092, a prolyl endopeptidase inhibitor, using quantitative EEG in young healthy volunteers.
    Morain P; Boeijinga PH; Demazières A; De Nanteuil G; Luthringer R
    Neuropsychobiology; 2007; 55(3-4):176-83. PubMed ID: 17700042
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EEG-mapping differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil.
    Saletu MT; Anderer P; Saletu-Zyhlarz GM; Mandl M; Arnold O; Nosiska D; Zeitlhofer J; Saletu B
    Eur Arch Psychiatry Clin Neurosci; 2005 Feb; 255(1):20-32. PubMed ID: 15538594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.